Yes, but there are certain circumstances, situations, where its out of your control and throws plan A out the window. Hindsight is great, management aren't perfect.
SI didn't expect the FDA to knock it back the first time. Got the votes from experts and everyone expected approval. Well, it didn't happen, not only once but twice.
Now all of a sudden the FDA said you can submit BLA without doing a Adult trial first. What did they see, to change their minds? We obviously don't know because the potency assays (which was in dispute) was not available to investors.
Also, GG coming and holding close to 20% of the company. If you were a punting man, this was a risk worth taking. (investing)
MSB Price at posting:
$1.31 Sentiment: Buy Disclosure: Held
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)